Bioverativ Inc (BIVV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIVV | AZN | AMGN | GILD | BMY |
| Company | Bioverativ Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 104.97 | 199.40 | 375.18 | 146.32 | 61.80 |
| High | 105.01 | 199.52 | 377.09 | 146.75 | 62.00 |
| Low | 104.97 | 195.84 | 364.18 | 143.35 | 60.26 |
| Latest | 104.98 | 196.07 | 363.53 | 144.12 | 60.50 |
| Change | +0.33 | -5.46 | -15.74 | -4.10 | -1.83 |
| % Change | +0.32% | -2.71% | -4.15% | -2.77% | -2.94% |
| Volume | 792,900 | 1,504,320 | 1,069,123 | 1,959,681 | 5,288,423 |
| 20-Day Average Volume | 2,587,600 | 2,375,229 | 2,732,224 | 7,594,555 | 13,417,799 |
| Previous Close | 104.65 | 201.53 | 379.27 | 148.22 | 62.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 104.18 | 202.02 | 376.00 | 150.05 | 60.95 |
| 20-Day Raw Stochastic | 98.80% | 37.20% | 16.67% | 4.44% | 55.05% |
| 20-Day Relative Strength | 86.97 | 50.15 | 52.02 | 51.46 | 57.56 |
| Weighted Alpha | +58.00 | +32.96 | +21.15 | +30.39 | +13.20 |
| Today's Opinion | N/A | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | N/A | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | N/A | 72% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 03/01/18 | -3.77% since 02/26/26 | -3.50% since 02/26/26 | -0.03% since 02/26/26 | -0.67% since 02/26/26 |
| Low | 104.14 on 03/06/18 | 195.84 on 03/05/26 | 364.18 on 03/05/26 | 143.36 on 03/05/26 | 60.26 on 03/05/26 |
| High | 105.01 on 03/08/18 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +1.78% since 02/08/18 | +4.88% since 02/05/26 | -0.48% since 02/05/26 | -3.78% since 02/05/26 | +1.97% since 02/05/26 |
| Low | 102.51 on 02/09/18 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 59.23 on 02/19/26 |
| High | 105.01 on 03/08/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +103.96% since 12/08/17 | +8.84% since 12/05/25 | +10.96% since 12/05/25 | +18.56% since 12/05/25 | +16.38% since 12/05/25 |
| Low | 51.25 on 12/11/17 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 105.01 on 03/08/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +83.92% since 09/08/17 | +20.13% since 09/05/25 | +29.05% since 09/05/25 | +24.92% since 09/05/25 | +28.74% since 09/05/25 |
| Low | 48.28 on 12/01/17 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 105.01 on 03/08/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,360,936 | 312,554,496 | 204,452,320 | 184,003,424 | 126,933,432 |
| Shares Outstanding, K | 108,220 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 1,168,500,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 355,600,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 328,700,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 96,300,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | N/A | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.95 on 02/13/18 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/02/18 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 38.05 | 22.03 | 17.25 | 18.14 | 9.95 |